Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

The causal role of human papillomavirus infections in cervical cancer has been documented
beyond reasonable doubt. The association is present in virtually all cervical cancer cases …

Early detection represents one of the most promising approaches to reducing the growing
cancer burden. It already has a key role in the management of cervical and breast cancer …

Several studies suggest that HPV testing is more sensitive than cytology in primary cervical
screening. These studies had different designs and were reported in different ways …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical neoplasia and cancer, based on recommendations from a formal review …

ORGANIZED SCREENING HAS CONTRIBUTED TO A DECLINE in cervical cancer
incidence and mortality over the past 50 years. However, women in developing countries …

Background Tests for the DNA of high-risk types of human papillomavirus (HPV) have a
higher sensitivity for cervical intraepithelial neoplasia grade 3 or worse (CIN3+) than does …

PURPOSE: Global data on age-specific prevalence of human papillomavirus (HPV) infection
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …

ContextHuman papillomavirus (HPV) DNA testing of women having Papanicolaou (Pap)
smears showing atypical squamous cells of undetermined significance (ASCUS) has clinical …